Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CES2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
FAM96B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRAD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDH16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CES3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CES4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CA7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAE1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CBFB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C16orf70 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B3GNT9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on